NASDAQ:APRE

Aprea Therapeutics, Inc Earning Date

USA |NASDAQ |USD

APRE Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 3, 2021 Sep 2021 $-0.45 $-0.48 $-0.58
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 3, 2021 Sep 2021 $0.00 $0.00 $0.00

Aprea Therapeutics, Inc's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.

APRE Earnings Date & History Chart

APRE Earnings & Revenue Forecast

APRE Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-0.40 $-0.47 $-0.32
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $-1.73 $-1.88 $-1.54
Dec 2022 5 $-1.63 $-2.09 $-1.25

APRE Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.40 $-0.41 $-0.41
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.73 $-1.74 $-1.74
Dec 2022 0 / 0 $-1.63 $-1.60 $-1.60

APRE Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 3 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $0.00 $0.00 $0.00
Dec 2022 5 $0.00 $0.00 $0.00

APRE Earnings Date & Revenue History

APRE Earnings History

|
Show More
Show More

APRE Revenue History

|
Show More
Show More

Aprea Therapeutics, Inc Next Earnings Date & Report

APRE Next Earnings Date & Report Preview: Sep 2021 (FQ)

APRE's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 4 analysts, the average EPS estimation for Aprea Therapeutics, Inc's next quarterly earnings is $-0.45, with a low EPS estimation of $-0.49, and a high estimation of $-0.40.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.45, the last 2 month trend is $-0.47, and the 3 month trend is $-0.47.

Based on 3 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Aprea Therapeutics, Inc Previous Earnings Dates & Reports

APRE Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Aprea Therapeutics, Inc's previous earnings date was Aug 12, 2021 for its fiscal quarter ended Jun 30, 2021.

APRE's earnings per share (EPS) was $-0.48, missing the consensus analysts forecast of $-0.47 by -2.43%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 4.35%, and higher than the same period a year before (Jun 2020) by -38.46%.

Revenues were $0.00.

The company reported a net income of $-10.25M.

Free cash flow for the quarter was $-7.75M , compared to $-11.52M last quarter and $-9.64M a year before.

APRE ended the quarter with $199.22K in total debt, a decrease of -23.17% compared to the previous quarter, and a decrease of -53.39% compared to the same quarter a year before.

APRE Previous Earnings Date & Report Recap: Dec 2020 (FY)

Aprea Therapeutics, Inc's previous annual earnings date was Mar 16, 2021 for its fiscal year ended Dec 31, 2020.

APRE's earnings per share (EPS) was $-2.54, missing the consensus analysts forecast of $-2.43 by 4.53% , and higher than the previous year's EPS (Dec 2019) by -57.17%.

Revenues were $0.00.

The company reported a net income of $-53.48M.

Aprea Therapeutics, Inc reported a free cash flow of $-41.83M for its fiscal year, compared to $-26.74M a year ago.

The company ended the fiscal year with $335.16K in total debt, a decrease of -38.50% compared to the previous year.